MiNK Therapeutics, Inc. business relationships
Companies named in MiNK Therapeutics, Inc.’s 10-K filed 2026-03-31, and public companies whose annual reports name MiNK Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 19% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in MiNK Therapeutics, Inc.’s annual report 1
“We are a party to an Amended and Restated Intercompany Services Agreement (the "New Intercompany Agreement") and an Intellectual Property Assignment and License Agreement with Agenus Inc. ("Agenus").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.